TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Thor Life Science Consulting AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
0
|
1,445
|
1,010 |
Financial expenses |
14
|
0
![]() |
0 |
Earnings before taxes |
-9
|
953
|
604 |
EBITDA |
-20
|
952
|
604 |
Total assets |
1,496
|
1,683
|
973 |
Current assets |
1,496
|
1,666
|
955 |
Current liabilities |
163
|
345
|
217 |
Equity capital |
1,313
|
1,316
|
755 |
- share capital |
34
|
33
|
36 |
Employees (average) |
1
![]() |
1
![]() |
1 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
87.8%
|
78.2%
|
77.6% |
Turnover per employee |
0
|
1,445
|
1,010 |
Profit as a percentage of turnover |
66.0%
|
59.8% | |
Return on assets (ROA) |
0.3%
|
56.6%
|
62.1% |
Current ratio |
917.8%
|
482.9%
|
440.1% |
Return on equity (ROE) |
-0.7%
|
72.4%
|
80.0% |
Change turnover |
-1,452
|
517
|
919 |
Change turnover % |
-100%
|
56%
|
1011% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.